183 related articles for article (PubMed ID: 29636754)
1. Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based Modeling.
Moyo D; Beattie L; Andrews PS; Moore JWJ; Timmis J; Sawtell A; Hoehme S; Sampson AT; Kaye PM
Front Immunol; 2018; 9():637. PubMed ID: 29636754
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study.
Salguero FJ; Garcia-Jimenez WL; Lima I; Seifert K
Parasit Vectors; 2018 Jan; 11(1):73. PubMed ID: 29386047
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.
Robert-Gangneux F; Drogoul AS; Rostan O; Piquet-Pellorce C; Cayon J; Lisbonne M; Herbelin A; Gascan H; Guiguen C; Samson M; Gangneux JP
PLoS One; 2012; 7(3):e33413. PubMed ID: 22457760
[TBL] [Abstract][Full Text] [Related]
4. A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection.
Albergante L; Timmis J; Beattie L; Kaye PM
PLoS Comput Biol; 2013; 9(11):e1003334. PubMed ID: 24363630
[TBL] [Abstract][Full Text] [Related]
5. Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.
Beattie L; Peltan A; Maroof A; Kirby A; Brown N; Coles M; Smith DF; Kaye PM
PLoS Pathog; 2010 Mar; 6(3):e1000805. PubMed ID: 20300603
[TBL] [Abstract][Full Text] [Related]
6. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
Murray HW; Luster AD; Zheng H; Ma X
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani: in vitro evidence of hepatocyte damage by Kupffer cells and immigrant macrophages in a murine model.
Kausalya S; Malla N; Ganguly NK; Mahajan RC
Exp Parasitol; 1993 Nov; 77(3):326-33. PubMed ID: 8224088
[TBL] [Abstract][Full Text] [Related]
8. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
[TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation.
Beattie L; Svensson M; Bune A; Brown N; Maroof A; Zubairi S; Smith KR; Kaye PM
Eur J Immunol; 2010 Jan; 40(1):117-23. PubMed ID: 19877019
[TBL] [Abstract][Full Text] [Related]
10. Tissue granuloma structure-function in experimental visceral leishmaniasis.
Murray HW
Int J Exp Pathol; 2001 Oct; 82(5):249-67. PubMed ID: 11703536
[TBL] [Abstract][Full Text] [Related]
11. Balancing immunity and pathology in visceral leishmaniasis.
Stanley AC; Engwerda CR
Immunol Cell Biol; 2007; 85(2):138-47. PubMed ID: 17146466
[TBL] [Abstract][Full Text] [Related]
12. A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival.
Beattie L; d'El-Rei Hermida M; Moore JW; Maroof A; Brown N; Lagos D; Kaye PM
Cell Host Microbe; 2013 Sep; 14(3):357-68. PubMed ID: 24034621
[TBL] [Abstract][Full Text] [Related]
13. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
14. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
Alexander CE; Kaye PM; Engwerda CR
Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
[TBL] [Abstract][Full Text] [Related]
15. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
16. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.
Paun A; Bankoti R; Joshi T; Pitha PM; Stäger S
PLoS Pathog; 2011 Jan; 7(1):e1001246. PubMed ID: 21253574
[TBL] [Abstract][Full Text] [Related]
17. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
Murray HW; Mitchell-Flack M; Zheng H; Ma X
Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner.
Cotterell SE; Engwerda CR; Kaye PM
Eur J Immunol; 1999 Jan; 29(1):203-14. PubMed ID: 9933102
[TBL] [Abstract][Full Text] [Related]
19. Ly6C
Terrazas C; Varikuti S; Oghumu S; Steinkamp HM; Ardic N; Kimble J; Nakhasi H; Satoskar AR
Sci Rep; 2017 Oct; 7(1):14693. PubMed ID: 29089636
[TBL] [Abstract][Full Text] [Related]
20. Lessons from other diseases: granulomatous inflammation in leishmaniasis.
Kaye PM; Beattie L
Semin Immunopathol; 2016 Mar; 38(2):249-60. PubMed ID: 26678994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]